News
-
-
-
COMMUNIQUÉ DE PRESSE
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim
XSeed Labs, a collaboration between BioMed X and Boehringer Ingelheim, establishes a new research team in Ridgefield, CT to focus on developing disease models for wound healing and fibrosis -
-
-
COMMUNIQUÉ DE PRESSE
BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project
BioMed X research unveils molecular mechanisms behind white matter deficits in schizophrenia. Collaboration with Boehringer Ingelheim leads to potential novel therapies for psychiatric disorders -
-
-
COMMUNIQUÉ DE PRESSE
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim
XSeed Labs, a collaboration between BioMed X and Boehringer Ingelheim, forms a new research team to develop disease models focusing on wound healing and fibrosis, aiming to bridge research and drug development for improved patient outcomes -
